| 000 | a | ||
|---|---|---|---|
| 999 |
_c15802 _d15802 |
||
| 003 | OSt | ||
| 005 | 20211229095601.0 | ||
| 008 | 211229b xxu||||| |||| 00| 0 eng d | ||
| 040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
| 100 |
_915174 _a Wang, Xuanxuan |
||
| 245 | _a Difficulties, opportunities and challenges of covid-19 by chinese medicine on china | ||
| 250 | _aVol.83(1), Jan-Feb | ||
| 260 |
_aMumbai _bIndian Journal of Pharmaceutical Science _c2021 |
||
| 300 | _a13-20p. | ||
| 520 | _aRecently, Coronavirus disease 2019 is the most frequent public health event in human history, spreads fastest, has the most extensive infection and the most difficult prevention and control, which has been abstracting the most impressive attention of the whole world. China, as the first outbreak place, has suffered seriously from the outbreak of Covid-19. The impact on domestic economy is profound and complex. How to effectively deal with once in a century global pandemic is still a world problem to be solved by the international community. Proceeding from the reality of China’s national conditions, following the objective law of prevention and control of infectious diseases, China has made great efforts to explore a set of effective “Chinese methods” in the control of epidemic situation and treatment of patients. Investigation, detection and monitoring with epidemiological investigation as the core has become the key link to cut off the chain of virus transmission and implement timely treatment for patients. To set up hospitals at different levels and to treat patients with mild, moderate and severe diseases according to their conditions, the combination of traditional Chinese and Western medicine has greatly reduced the infection rate and death rate and improved the cure rate. From the whole industrial chain, the primary industry, the secondary industry and the tertiary industry are all almost affected. However, some difficulties, opportunities and challenges of Covid-19 should be paid attention to and grasped. | ||
| 650 | 0 |
_94639 _aPHARMACEUTICS |
|
| 700 |
_915175 _aLi, Hua |
||
| 773 | 0 |
_tIndian journal of pharmaceutical sciences _dNew Delhi |
|
| 856 |
_uhttps://www.ijpsonline.com/articles/the-difficulties-opportunities-and-challenges-of-covid19-by-chinese-medicine-on-china.pdf _yClick here |
||
| 942 |
_2ddc _cAR |
||